Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embolization and chemoembolization for hepatocellular carcinoma.

B Damascelli1, F Garbagnati, A Marchianò

  • 1Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.

The Italian Journal of Gastroenterology
|February 1, 1992
PubMed
Summary

This study investigated chemoembolization for hepatocellular carcinoma, finding microencapsulated Mitomycin improved patient survival compared to controls. Survival rates were significantly higher in the treated group at 12, 36, and 60 months.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential.

Revue neurologique·2026
Same author

Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study.

ESMO open·2025
Same author

Prospective Registry Study on Thermal Liver Ablation of Primary and Secondary Liver Tumours Named the A-IMAGIO Study.

Cardiovascular and interventional radiology·2025
Same author

Phenotyping pleural effusion in patients hospitalized in Internal Medicine wards with decompensated heart failure.

European journal of internal medicine·2023
Same author

Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19.

BMC infectious diseases·2023
Same author

Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Area of Science:

  • Hepatobiliary Medicine
  • Interventional Radiology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) management often involves embolization techniques.
  • Understanding liver vasculature is crucial for targeted therapies.
  • Existing chemoembolization methods lack standardized stability data.

Purpose of the Study:

  • To evaluate the rationale and efficacy of embolization and chemoembolization for HCC.
  • To assess the use of microencapsulated Mitomycin in HCC treatment.
  • To compare survival outcomes of treated patients versus a control group.

Main Methods:

  • Review of embolization rationale and liver anatomy.
  • Application of a novel chemoembolization technique using microencapsulated Mitomycin.

Related Experiment Videos

  • Retrospective survival analysis of 32 treated patients against a control cohort.

    • Main Results:

    • Microencapsulated Mitomycin demonstrated improved reproducibility.
    • The treated group showed significantly longer survival rates.
    • 12-month survival: 70% (treated) vs. 37% (control); 36-month: 45% vs. 0%; 60-month: 15% vs. 0%.

    Conclusions:

    • Microencapsulated Mitomycin offers a reproducible and effective chemoembolization strategy for HCC.
    • This formulation significantly enhances long-term survival in HCC patients.
    • Further research into standardized chemoembolization techniques is warranted.